The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune-related adverse events and symptom burden in patients with melanoma receiving adjuvant immune checkpoint inhibitor.
 
Noha Abdel-Wahab
Honoraria - ChemoCentryx
Consulting or Advisory Role - ChemoCentryx
 
Teresa Kus
No Relationships to Disclose
 
Salah-Eddine Bentebibel
No Relationships to Disclose
 
Jennifer Leigh McQuade
Honoraria - Bristol-Myers Squibb/Roche; Merck
Consulting or Advisory Role - Bristol Myer Squibb; Roche Pharma AG
Travel, Accommodations, Expenses - Merck
 
Isabella Claudia Glitza
Honoraria - Amgen
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Novartis
Speakers' Bureau - Array BioPharma
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer
 
Rodabe Navroze Amaria
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Iovance Biotherapeutics; Nektar; Novartis; Obsidian Therapeutics
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); iovance Biotherapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Sapna Pradyuman Patel
Honoraria - Delcath Systems; Immunocore; Merck
Consulting or Advisory Role - Castle Biosciences; TriSalus Life Sciences
Research Funding - Bristol-Myers Squibb (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); InxMed (Inst); Lyvgen Biopharma (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst); Seagen (Inst); Syntrix Biosystems (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - TriSalus Life Sciences
Other Relationship - Immunocore
 
Michael K.K. Wong
Consulting or Advisory Role - Castle Biosciences; Pfizer; Regeneron
 
Hussein A. Tawbi
Consulting or Advisory Role - Array BioPharma; Boxer Capital; Bristol-Myers Squibb; Eisai; Genentech/Roche; Iovance Biotherapeutics; Jazz Pharmaceuticals; Karyopharm Therapeutics; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Dragonfly Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); RAPT Therapeutics (Inst)
 
Michael A. Davies
Consulting or Advisory Role - ABM; Apexigen; Array BioPharma; Bristol-Myers Squibb; Eisai; Genentech/Roche; NanoString Technologies; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Pfizer (Inst); Sanofi (Inst)
 
Susan K. Peterson
No Relationships to Disclose
 
Sanjay Shete
Stock and Other Ownership Interests - 23andMe; Vertex
 
Cassian Yee
No Relationships to Disclose
 
Annemieke Kavelaars
No Relationships to Disclose
 
Maria E. Suarez-Almazor
Consulting or Advisory Role - Abbvie/Genentech; Agile Therapeutics; AMAG Pharmaceuticals; Avenue Therapeutics; Celgene/Bristol-Myers Squibb; ChemoCentryx; Gilead Sciences
 
Adi Diab
No Relationships to Disclose